Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial
Titel:
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial
Auteur:
Patnaik, Amita Weiss, Glen J. Rasco, Drew W. Blaydorn, Lisa Mirabella, Amy Beeram, Murali Guo, Wei Lu, Sharon Danaee, Hadi McEachern, Kristen Im, Ellie Sachdev, Jasgit C.